Looking to the Horizon: Earlier Diagnosis and Advances in Treating Neovascular Age-Related Macular Degeneration - How Earlier Detection and Effective Testing Lead to Better Outcomes and Lower Treatment Burden

Looking to the Horizon: Earlier Diagnosis and Advances in Treating Neovascular Age-Related Macular Degeneration - How Earlier Detection and Effective Testing Lead to Better Outcomes and Lower Treatment Burden is organized by Paradigm Medical Communications, LLC.

Release Date: August 30, 2019
Expiration Date: August 30, 2020

Accreditation:
Physician Credit Designation Statement:
Paradigm Medical Communications, LLC designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PA Continuing Education:
PAs may claim a maximum of 0.5 Category 1 credit for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.

Learning Objectives:
Upon proper completion of this activity, participants should be better able to:
• Identify existing and emerging imaging tools to facilitate the early diagnosis and monitoring of disease progression in nAMD

Additional details will be posted as soon as information is available.